Several nutritional pitfalls commonly occur when individuals begin GLP-1 therapy, potentially compromising health outcomes or treatment efficacy
The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, constipation, and abdominal pain, which typically diminish over time as the body adjusts to the medication
Standard protocols using 1 to 2 mg daily are operating at a tiny fraction of these thresholds
2.5 mg: Initiation dose, used for the first 4 weeks to help the body adjust
These studies highlight the potential for developing specific bacteria- and metabolite-based therapeutic interventions to improve outcomes in for example obesity and atherosclerosis
Its rooted in real neurological changes that come with perimenopause and midlife